Sleep Software Market

The global sleep software market is forecasted to reach USD 1,569.2 million by 2030 from USD 878.9 million in 2024, at a CAGR of 10.1% during the forecast period. The demand for sleep software is driven by an increased prevalence of sleep disorders and an increased awareness about the impact of sleep health on overall well-being. Advancements in wearable technology, AI integration, and telehealth adoption have enhanced accessibility and personalization. Growing demand for non-invasive solutio ns and the emphasis on mental health further boost the growth of this market. Corporate wellness programs and affordable pricing also contribute to broader adoption.

The key players operating in the sleep software market include Koninklijke Philips N.V. (Netherlands), Cadwell Industries Inc. (US), COMPUMEDICS LIMITED (Australia), Neurovirtual. (US), NIHON KOHDEN CORPORATION (Japan), Nox Medical (Iceland), Natus Medical Incorporated (ARCHIMED) (US), RXNT (US), Resmed (US), Cleveland Medical Devices Inc. (US), SOMNOmedics AG (Germany), CIDELEC (France), Calm (US), Sleep Cycle (Sweden), Headspace Inc. (US), Löwenstein Medical SE & Co. KG (Germany), CamNtech Ltd (United Kingdom), Fisher & Paykel Healthcare Limited. (New Zealand), BioSerenity (France), VYAIRE MEDICAL INC (US), and Inspire Medical Systems, Inc. (US). These companies have adopted organic & inorganic strategies such as product launches, product updates, expansions, partnerships, collaborations, and acquisitions to strengthen their market presence in the sleep software market.

To know about the assumptions considered for the study download the pdf brochure

Koninklijke Philips N.V. (Royal Philips) is the parent company of the Philips Group. It is a multinational medtech company specializing in health technology, offering products and services across healthcare systems, personal health, and consumer electronics. Philips offers various health technology solutions, including systems for image-guided therapy, ultrasound, radiology, hospital patient monitoring, respiratory care, and sleep therapy. They also provide enterprise informatics, consulting, and support services to optimize healthcare delivery. The company operates through four segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. It provides sleep software through the connected care segment. The Connected Care segment offers integrated solutions across hospital, ambulatory, and home care settings, focusing on patient monitoring, diagnostics, emergency care, sleep and respiratory therapy, and enterprise informatics. Philips Sleep & Respiratory Care offers solutions for sleep apnea, COPD, and respiratory conditions, including diagnostics, therapy, ventilators, and chronic care management in both hospital and home settings. Philips offers a range of sleep software solutions, including DreamMapper for therapy management, Sleepware G3 for sleep study analysis, Care Orchestrator for workflow optimization, EncorePro 2 for CPAP/BiPAP data management, and Actiware for sleep and activity data analysis. These solutions aim to improve patient care and clinical outcomes. Some of its significant subsidiaries include Philips Oral Healthcare, LLC (US), Philips GmbH (Germany), Philips Ultrasound, Inc. (US), and Philips Consumer Lifestyle B.V. (Netherlands). The company operates in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

ResMed is one of the leading providers of digital health and cloud-connected medical products for sleep apnea. The company develops, manufactures, distributes, and markets medical products for diagnosing, treating, and managing respiratory disorders, especially sleep-disordered breathing (SDB). The company provides diagnostic products, mask systems, headgear, other accessories, dental devices, and cloud-based software informatics solutions. The company operates through two segments: Total Sleep & Respiratory Care and Software as a Service. ResMed offers the myAir app that provides personalized feedback and progress tracking for users of its sleep therapy devices. The app helps optimize CPAP therapy by monitoring device usage, mask fit, and sleep quality. The company has a widespread presence globally in over 140 countries through a network of distributors and a direct sales force spanning North America, Latin America, Europe, the Asia Pacific, and others. ResMed owns subsidiaries such as Brightree LLC, MatrixCare (a cloud-based software company), and Propeller Health (a digital therapeutics company).

Related Reports:

Sleep Software Market by Function (Sleep Tracking, Analysis, Disorder Management, Improvement), Indication (Insomnia, Sleep Apnea), Offering (Platforms, Apps (Mobile)), End-user (Providers, Individual), Deployment, Type, & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com